Clinical trial · Interventional
Nutritional Supplementation in Patients With no Signs of Malnutrition
The Effect of Nutritional Supplementation in Cancer Patients With no Clinical Signs of Malnutrition
NCT01894828CI-TRIAL-00011298unknownPhase 4ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of the study was to assess the effect of nutritional supplementation on nutritional status and postoperational complications in cancer patients with no clinical signs of malnutrition
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Abdominal Neoplasm | — | UNRESOLVED | — |
| Primary Neoplasm | Primary Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Secondary Neoplasm | Secondary Neoplasm | ONTOLOGY_EXACT | 0.98 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Nutritional supplements | Dietary Supplement | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Nutritional supplements
- description
- Patients are asked to drink two 200ml bottles of nutritional supplement daily
- interventionNames
- Dietary Supplement: Nutritional supplements
- type
- NO_INTERVENTION
- label
- Control
- description
- Patients are asked to keep on to their normal diet. No supplementation is introduced
Primary outcomes (1)
- measure
- Improvement of nutritional status
- timeFrame
- After 14 days
- description
- The aim of the study was to assess if nutritional supplementation improves nutritional status of patients with no clinical signs of malnutrition. Nutritional status improvement will be assessed by change in anthropometric (body weight (kg)) and laboratory (albumin, total protein, transferrin level, total lymphocyte count) parameters.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Primary or secondary resectable gastrointestinal and abdominal malignancy * No signs of malnutrition at qualification for surgery * General performance \>70 Karnofsky scale * Informed consent Exclusion Criteria: * history of radio or chemotherapy * signs of mechanical ileus * other major gastrointestinal diseases * type 1 diabetes * autoimmunological diseases requiring systemic steroids * signs of infection * renal and/or liver failure
References
Publications (0)
Data not yet available
No reference posted for this study.